Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett

Showing results (211-220 of 330) with videos related to

Pageof 33
Sort By:
Oncotarget|October 18, 2016
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor controlPravin Kesarwani, Paramita Chakraborty, Radhika Gudi, et al.
Oncology|May 3, 2018
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular CarcinomaMelanie B Thomas, Elizabeth Garrett-Mayer, Munazza Anis, et al.
JCO Oncology Advances|June 23, 2025
Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute StudiesJoseph M Unger, Hillary S Andrews, Laura A Levit, et al.
Chest|June 4, 2011
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancerJessica S Wang Memoli, Ezzat El-Bayoumi, Nicholas J Pastis, et al.
Cancer Research|February 3, 2006
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signalingRajani Ravi, Ephraim J Fuchs, Ajay Jain, et al.
Pigment Cell & Melanoma Research|June 18, 2014
Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentationJonathan M Eby, Hee-Kap Kang, Jared Klarquist, et al.
Molecular Cancer Therapeutics|July 10, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Molecular Cancer Therapeutics|August 14, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Cancer|March 15, 2023
Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Clinical Oncology RegistryDax Kurbegov, Suanna S Bruinooge, Xiudong Jennifer Lei, et al.
The Laryngoscope|July 10, 2016
Smoking status and symptom burden in surgical head and neck cancer patientsKatherine R Sterba, Elizabeth Garrett-Mayer, Matthew J Carpenter, et al.
Pageof 33

Showing results (211-220 of 330) with videos related to

Sort By:
Pageof 33
Oncotarget|October 18, 2016
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor controlPravin Kesarwani, Paramita Chakraborty, Radhika Gudi, et al.
Oncology|May 3, 2018
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular CarcinomaMelanie B Thomas, Elizabeth Garrett-Mayer, Munazza Anis, et al.
JCO Oncology Advances|June 23, 2025
Impact of the COVID-19 Pandemic Mitigation Strategies on Cancer Treatment Trials: A Meta-Analysis of Industry and National Cancer Institute StudiesJoseph M Unger, Hillary S Andrews, Laura A Levit, et al.
Chest|June 4, 2011
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancerJessica S Wang Memoli, Ezzat El-Bayoumi, Nicholas J Pastis, et al.
Cancer Research|February 3, 2006
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signalingRajani Ravi, Ephraim J Fuchs, Ajay Jain, et al.
Pigment Cell & Melanoma Research|June 18, 2014
Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentationJonathan M Eby, Hee-Kap Kang, Jared Klarquist, et al.
Molecular Cancer Therapeutics|July 10, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Molecular Cancer Therapeutics|August 14, 2025
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Dabrafenib and Trametinib Clinical TrialsVarun Jhanji, Jacob Duncan, Taylor Gardner, et al.
Cancer|March 15, 2023
Rate of COVID-19 vaccination among patients with cancer who tested positive for severe acute respiratory syndrome-coronavirus 2: Analysis of the American Society of Clinical Oncology RegistryDax Kurbegov, Suanna S Bruinooge, Xiudong Jennifer Lei, et al.
The Laryngoscope|July 10, 2016
Smoking status and symptom burden in surgical head and neck cancer patientsKatherine R Sterba, Elizabeth Garrett-Mayer, Matthew J Carpenter, et al.
Pageof 33